FindTrial
Sign In

Remdesivir placebo

DRUG4 trials

Sponsors

Capital Medical University, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

COVID-19Covid19RemdesivirSARS-CoV-2

Phase 3

A Trial of Remdesivir in Adults With Mild and Moderate COVID-19
SuspendedNCT04252664
Capital Medical UniversityCOVID-19, SARS-CoV-2
Start: 2020-02-12End: 2020-04-27Target: 308Updated: 2020-04-15
A Trial of Remdesivir in Adults With Severe COVID-19
TerminatedNCT04257656
Capital Medical UniversityCOVID-19, Remdesivir, SARS-CoV-2
Start: 2020-02-06End: 2020-04-10Updated: 2020-04-15
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
CompletedNCT04843761
National Institute of Allergy and Infectious Diseases (NIAID)Covid19
Start: 2021-04-20End: 2022-11-20Updated: 2025-10-24
Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
CompletedNCT06729593
National Institute of Allergy and Infectious Diseases (NIAID)Covid19
Start: 2021-04-20End: 2022-11-20Updated: 2025-10-09

Related Papers

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
2023-06-1913 citations
Lenalidomide and Rituximab Regimen Combined With Intravitreal Methotrexate Followed by Lenalidomide Maintenance for Primary Vitreoretinal Lymphoma: A Prospective Phase II Study.
2021-06-2413 citations
SARS‐CoV‐2 virus infection: Targets and antiviral pharmacological strategies
Journal of Evidence-Based Medicine2020-10-1445 citations
561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19
Open Forum Infectious Diseases2020-10-015 citations
72. Remdesivir vs Standard Care in Patients with Moderate covid-19
Open Forum Infectious Diseases2020-10-012 citations
Remdesivir: Mechanism and Effectiveness for Coronavirus Disease 2019 (COVID-19)
Pharmaceutical Sciences and Research2020-08-054 citations
A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study
Advanced Science2020-07-14174 citations
Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China
Frontiers in Medicine2020-05-2743 citations
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
2020-05-2446 citations
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis.
2020-05-166 citations
Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
British Journal of Clinical Pharmacology2020-05-0211 citations
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
2020-04-292469 citations
Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment
Chinese Medical Journal2020-03-194 citations